Skip to content
WeighLab

Midi Health vs Boston Medical Group

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Midi Health

Provider comparison

Women already managing menopause who want their GLP-1 prescriber on the same platform, with no separate membership fee.

Semaglutide / month
$166/mo0.5 mg dose, plus a separate fee, compounded
Tirzepatide / month
$210/mo2.5 mg dose, plus a separate fee, compounded
Index 57/100 · Grade CChecked August 2026

Boston Medical Group

Provider comparison

Cost-first shoppers who want a clinician-run 12-week program and can accept a price quoted as a range rather than a rate.

Semaglutide / month
$199/moStarting strength, rising with dose, compounded
Tirzepatide / month
Not disclosed
Index 56/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Midi Health has the higher Cost-Efficiency Index: 57/100 versus 56/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Midi Health
All 50 states
Boston Medical Group
Weight-loss coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Midi Health

Boston Medical Group

Semaglutide / month
Midi Health: $166/mo0.5 mg dose, plus a separate fee, compounded
Boston Medical Group: $199/moStarting strength, rising with dose, compounded
Tirzepatide / month
Midi Health: $210/mo2.5 mg dose, plus a separate fee, compounded
Boston Medical Group: Not disclosed
Semaglutide / year (modeled)
Midi Health: $1,992
Boston Medical Group: $2,388
Tirzepatide / year (modeled)
Midi Health: $2,520
Boston Medical Group: —
State availability
Midi Health: All 50 states
Boston Medical Group: Weight-loss coverage not published
Oral / sublingual option listed
Midi Health: Not listed
Boston Medical Group: Not listed
Brand-name access listed
Midi Health: Not confirmed
Boston Medical Group: Not confirmed
Provider facts checked
Midi Health: August 2026
Boston Medical Group: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Midi Health

Women already managing menopause who want their GLP-1 prescriber on the same platform, with no separate membership fee.

Reasons to consider it

  • No membership fee — the site states outright 'You only pay for your care and your medications'
  • Medication price already includes shipping and supplies, so the listed number is closer to the true out-of-pocket cost than sites that add fees later
  • Dose-tiered pricing is published transparently: compounded semaglutide $165.90-$355.00/mo, compounded tirzepatide $210.00-$434.00/mo depending on dose

What to weigh up

  • The advertised 'Weekly doses start at $34' teaser on the weight-management overview page refers to microdosing, not the standard program — the real 4-week program cost starts at $165.90/mo, over 4x the teaser figure
  • Weight care is not Midi's core identity — it's layered onto a menopause/HRT platform, so patients whose only need is GLP-1 may find a weight-loss-only provider more streamlined
  • No flat cash price is published for brand-name Wegovy/Zepbound — those go through the patient's own pharmacy/insurance, so actual cost is unknown until benefits are checked

Boston Medical Group

Cost-first shoppers who want a clinician-run 12-week program and can accept a price quoted as a range rather than a rate.

Reasons to consider it

  • An established medical group with a defined 12-week program rather than an open-ended subscription
  • Public pages describe a twelve-week program and monthly shipments, but disagree on the price
  • Semaglutide is prescribed and dispensed under a compounded pathway with clinician oversight

What to weigh up

  • The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
  • The site quotes conflicting twelve-week totals: $699 on its cost page and $999 on its program-steps page, which separately names a $100 telemedicine platform fee; get a written all-in quote
  • The weight-loss landing page carries no price at all; the numbers are two pages deeper, in the FAQ and the costs page

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Midi HealthBoston Medical Group
Normalized Cost/Month
Midi Health:
49/100
Boston Medical Group:
45/100
Price Transparency
Midi Health:
20/100
Boston Medical Group:
78/100
Nationwide Access
Midi Health:
86/100
Boston Medical Group:
24/100
Formulation Options
Midi Health:
66/100
Boston Medical Group:
53/100
Clinical Oversight
Midi Health:
77/100
Boston Medical Group:
88/100
Contract Flexibility
Midi Health:
55/100
Boston Medical Group:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.